A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

Aún no traducido Aún no traducido
Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2007
The purpose of this study is to evaluate the efficacy, safety, tolerability, and impact on quality of life of two different doses of belimumab administered in addition to standard therapy in subjects with active, autoantibody-positive systemic lupus erythematosus (SLE) disease.
Epistemonikos ID: cee7b5ab5e18a5c86a67a1950571ef16b1ae1fc4
First added on: May 04, 2024